Education
About Us
Working with TipRanks
Follow Us
PreveCeutical Medical (PRVCF)
:PRVCF
RESEARCH TOOLSreports
PRVCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume198.43K
Average Volume (3M)39.34K
Market Cap
$12.45M
Enterprise Value$18.00M
Total Cash (Recent Filing)$5.47K
Total Debt (Recent Filing)$4.60M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding570,649,500
10 Day Avg. Volume13,634
30 Day Avg. Volume39,340
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-3.55K
Enterprise Value/Ebitda-13.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PreveCeutical Medical News
PRVCF FAQ
What was PreveCeutical Medical ’s price range in the past 12 months?
PreveCeutical Medical lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is PreveCeutical Medical ’s market cap?
PreveCeutical Medical ’s market cap is $12.45M.
When is PreveCeutical Medical ’s upcoming earnings report date?
PreveCeutical Medical ’s upcoming earnings report date is Aug 21, 2025 which is in 13 days.
How were PreveCeutical Medical ’s earnings last quarter?
Currently, no data Available
Is PreveCeutical Medical overvalued?
According to Wall Street analysts PreveCeutical Medical ’s price is currently Overvalued.
Does PreveCeutical Medical pay dividends?
PreveCeutical Medical does not currently pay dividends.
What is PreveCeutical Medical ’s EPS estimate?
PreveCeutical Medical ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PreveCeutical Medical have?
PreveCeutical Medical has 570,649,500 shares outstanding.
What happened to PreveCeutical Medical ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PreveCeutical Medical ?
Currently, no hedge funds are holding shares in PRVCF
Company Description
PreveCeutical Medical
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
BriaCell Therapeutics
―
Hemostemix
―
Sirona Biochem
―
PharmaTher Holdings Ltd
―
Ownership Overview
Options Prices
Currently, No data available
---